Clinical Trials/NCT02304562

NCT02304562

Unknown

Phase 1

Umbilical Cord Blood-derived Mesenchymal Stem Cells in Regeneration of Sweat Glands and Body Repair

Chinese PLA General Hospital1 site in 1 country50 target enrollmentJanuary 2013

ConditionsSweat Gland Diseases

Overview

Phase: Phase 1
Intervention: Not specified
Conditions: Sweat Gland Diseases
Sponsor: Chinese PLA General Hospital
Enrollment: 50
Locations: 1
Primary Endpoint: Frequency of Adverse Events
Last Updated: 11 years ago

Overview Investigators Eligibility Criteria Outcomes Sites Similar Trials

Overview

Brief Summary

Patients with skin injury treated with Umbilical Cord Blood-derived Mesenchymal Stem Cells,such as deep burn damaged sweat glands,Effectiveness of Umbilical Cord Blood-derived Mesenchymal Stem Cells in Regeneration of Sweat Glands and Body Repair is determined.

Registry

clinicaltrials.gov

Start Date

January 2013

End Date

December 2017

Last Updated

11 years ago

Study Type

Interventional

Study Design

Single Group

Sex

All

Investigators

Sponsor

Chinese PLA General Hospital

Responsible Party

Principal Investigator

Principal Investigator

Xiaobing Fu

Academician

Chinese PLA General Hospital

Eligibility Criteria

Inclusion Criteria

•Burn area:10-20％TBSA

Exclusion Criteria

•Have influence on the speed of wound healing of patients with chronic diseases

Outcomes

Primary Outcomes

Frequency of Adverse Events

Time Frame: 6 months

Frequency and severity of Adverse Events

Secondary Outcomes

Active and inactive lesion count(6 months)

Study Sites (1)

Loading locations...

Similar Trials

Mesenchymal Stem Cells Treat Liver CirrhosisLiver Cirrhosis

NCT01233102Yufang Shi200

Transplantation of Umbilical Cord-derived Mesenchymal Stem Cells Via Different RoutesCerebral Palsy

NCT03414697The First Affiliated Hospital of Dalian Medical University44

Clinical Study of Umbilical Cord Tissue Mesenchymal Stem Cells (UC-MSC) for Treatment of OsteoarthritisOsteoarthritis of the Knee

NCT02237846Translational Biosciences

Umbilical Cord Derived Mesenchymal Stem Cells Therapy in Hypoxic Ischemic EncephalopathyHypoxic Ischemic Encephalopathy

NCT01962233Hebei Medical University10

Umbilical Cord Derived Mesenchymal Stem Cells Therapy in Parkinson's DiseaseParkinson's Disease

NCT03550183Hebei Newtherapy BIo-Pharma technology Co., Ltd.20